Investor
BIO-Europe Spring
Europe's premier spring partnering conference connects biotechnology companies with global pharmaceutical executives and investors to secure development deals.
- When
- March, Late March
- Where
- Rotating
- Format
- In person
- Organiser
- EBD Group
- Region
- Europe
- Scale
- About 3,500 attendees
- Founded
- 2007
The briefing
BIO-Europe Spring is the counterpart to the autumn BIO-Europe event, focusing on licensing deals and investments in European life sciences. The event relies on a proprietary partnering system that facilitates thousands of one on one meetings over three days. Biopharmaceutical companies present their pipelines to prospective investors, major drug makers, and strategic development partners. This is a critical venue for early stage biotech companies seeking non dilutive funding or development collaborations.
What to expect
- Biopharma licensing and option agreements
- Early stage biotech venture financing rounds
- Therapeutic asset development collaborations
- Regional biotechnology ecosystem updates
Who is in the room
Biotech executives, pharmaceutical business development professionals, life science venture capitalists, and academic technology transfer officers attend.
Background
Launched to complement the massive autumn BIO-Europe conference, BIO-Europe Spring has moved to different European cities each year to highlight regional hubs. It has become a crucial midyear milestone for life science dealmakers.
Related events
Running this event, or spotted something out of date?